Literature DB >> 19530414

Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. Alergológica 2005.

M Ferrer1.   

Abstract

INTRODUCTION: In spite of the impact on quality of life, little attention has been given to chronic urticaria.
OBJECTIVE: To describe the morbidity and features of urticaria and compare the results with the other allergic diseases included in this study.
RESULTS: Urticaria is the fourth most prevalent condition after rhinitis, asthma and drug allergy. Despite this position, the number of patients who needed to visit emergency departments was higher (54.4%) than the rest of the sample (24.6%) (P < .001). The percentage of urticaria/angioedema patients with work absences was also higher than the rest of the sample suffering from other allergic conditions. We found significant differences in school performance between urticaria/angioedema children and children from of the rest of the sample (P = .029). Paired analysis identified significant differences in percentages of "bad school performance" for children suffering from urticaria/angioedema. Patients suffering from chronic urticaria scored in the lowest 25th percentile on physical impact. On psychological impact, urticaria patients scored below the 20th percentile of the general population. The general trend was to order extensive laboratory test for patients suffering from urticaria. In the present study, only one patient had a systemic disease, 13 patients had autoimmune and endocrine diseases often present with chronic urticaria. In spite of the insistence on the possible role of infections in chronic urticaria, in our study an infection could only be demonstrated in three patients.
CONCLUSION: Based on these results, we believe that urticaria is a disease with significant morbidity and involves heavy use of healthcare services and as such deserves more resources and attention.

Entities:  

Mesh:

Year:  2009        PMID: 19530414

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  22 in total

1.  Schnitzler syndrome: an under-diagnosed clinical entity.

Authors:  Tania Jain; Chetan P Offord; Robert A Kyle; David Dingli
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

Review 2.  Pharmacologic Management of Chronic Urticaria in Pediatric Patients: The Gap Between Guidelines and Practice.

Authors:  Paul V Williams
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

Review 3.  Histamine H2-receptor antagonists for urticaria.

Authors:  Zbys Fedorowicz; Esther J van Zuuren; Nianfang Hu
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

4.  [Chronic urticaria. Prevalence, course, prognostic factors and impact].

Authors:  K Weller; S Altrichter; E Ardelean; K Krause; M Magerl; M Metz; F Siebenhaar; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

Review 5.  Urticaria.

Authors:  Pavel Kolkhir; Ana M Giménez-Arnau; Kanokvalai Kulthanan; Jonny Peter; Martin Metz; Marcus Maurer
Journal:  Nat Rev Dis Primers       Date:  2022-09-15       Impact factor: 65.038

Review 6.  Management of urticaria: not too complicated, not too simple.

Authors:  M Ferrer; J Bartra; A Giménez-Arnau; I Jauregui; M Labrador-Horrillo; J Ortiz de Frutos; J F Silvestre; J Sastre; M Velasco; A Valero
Journal:  Clin Exp Allergy       Date:  2015-04       Impact factor: 5.018

Review 7.  Chronic urticaria: new management options.

Authors:  Paul A Greenberger
Journal:  World Allergy Organ J       Date:  2014-11-05       Impact factor: 4.084

8.  Impact of chronic urticaria on the quality of life of patients followed up at a university hospital.

Authors:  Gabriela Andrade Coelho Dias; Gisele Viana Pires; Solange Oliveira Rodrigues do Valle; Sérgio Duarte Dortas; Soloni Levy; Alfeu Tavares França; Ilaria Baiardini; Walter Giorgio Canonica
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

9.  The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU.

Authors:  M Maurer; M Abuzakouk; F Bérard; W Canonica; H Oude Elberink; A Giménez-Arnau; C Grattan; K Hollis; A Knulst; J-P Lacour; C Lynde; A Marsland; D McBride; A Nakonechna; J Ortiz de Frutos; C Proctor; G Sussman; C Sweeney; H Tian; K Weller; D Wolin; M-M Balp
Journal:  Allergy       Date:  2017-07-10       Impact factor: 13.146

10.  Comparison of Efficacy, Safety and Cost-effectiveness of Rupatadine and Olopatadine in Patients of Chronic Spontaneous Urticaria: A Randomized, Double-blind, Comparative, Parallel Group Trial.

Authors:  Ganesh N Dakhale; Sumit S Wankhede; Mohini S Mahatme; Sachin K Hiware; Dharmendra B Mishra; Sujata S Dudhgaonkar
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.